raloxifene hydrochloride has been researched along with Left Ventricular Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atar, İ; Bal, UA; Kuşcu, E; Müderrisoğlu, H; Öktem, M; Yıldırır, A; Zeyneloğlu, HB | 1 |
| Asanuma, H; Beppu, S; Hori, M; Ishikura, F; Kitakaze, M; Liao, Y; Minamino, T; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
1 trial(s) available for raloxifene hydrochloride and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
The effect of raloxifene on left ventricular hypertrophy in postmenopausal women: A prospective, randomized, and controlled study.
Topics: Administration, Oral; Echocardiography; Female; Humans; Hypertrophy, Left Ventricular; Middle Aged; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome | 2015 |
1 other study(ies) available for raloxifene hydrochloride and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice.
Topics: Animals; Constriction; Echocardiography; Hemodynamics; Hypertrophy, Left Ventricular; Leucine; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Pressure; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2004 |